Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
This report contains market size and forecasts of Heparin Sodium Injection in global, including the following market information:
Global Heparin Sodium Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Heparin Sodium Injection Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Heparin Sodium Injection companies in 2021 (%)
The global Heparin Sodium Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1, 000 USP Units / mL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Heparin Sodium Injection include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, Changzhou Qianhong Bio-pharma, Changshan Biochemical, Pharma Action and Baxter, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Heparin Sodium Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heparin Sodium Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Heparin Sodium Injection Market Segment Percentages, by Type, 2021 (%)
1, 000 USP Units / mL
5, 000 USP Units / mL
10, 000 USP Units / mL
Global Heparin Sodium Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Heparin Sodium Injection Market Segment Percentages, by Application, 2021 (%)
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Other
Global Heparin Sodium Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Heparin Sodium Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Heparin Sodium Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Heparin Sodium Injection revenues share in global market, 2021 (%)
Key companies Heparin Sodium Injection sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Heparin Sodium Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shenzhen Hepalink
Bioibérica
Nanjing King-friend
Pfizer
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Changshan Biochemical
Pharma Action
Baxter
Dongying Tiandong Pharmaceutical
Opocrin
Aspen Oss
Xinbai Pharmaceuticals
Yino Pharma Limited
Sichuan Deebio